@prefix orcid: <https://orcid.org/> .
@prefix this: <http://purl.org/np/RAS63BX8gGZ473Njn7vCUWzpCshGot0VeKdZ5qxXjMH6g> .
@prefix sub: <http://purl.org/np/RAS63BX8gGZ473Njn7vCUWzpCshGot0VeKdZ5qxXjMH6g#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix ns2: <http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:> .
@prefix ns1: <http://wordnet-rdf.princeton.edu/lemma/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix ns3: <http://twoc-nlp-database-server-1:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:ezgtl5fj&rows=> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubInfo .
}

sub:assertion {
  <https://uts.nlm.nih.gov/uts/umls/concept/C0245109> ns1:result <https://uts.nlm.nih.gov/uts/umls/concept/C0229671> .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2021-12-16T20:10:36.592326"^^xsd:dateTime;
    prov:wasGeneratedBy "S&T TWOC project version 2" .
  
  sub:version prov:value "2"^^xsd:integer .
  
  rdf:OBJECT rdfs:label "in rapid clinical improvement , reduction in serum inflammatory markers and a marked recovery in CMR-based markers of inflammation and contractile dysfunction" .
  
  rdf:OBJECT-POSITION rdfs:label "44"^^xsd:integer .
  
  rdf:PREDICATE rdfs:label "resulted" .
  
  rdf:PREDICATE-POSITION rdfs:label "[100]" .
  
  rdf:SUBJECT rdfs:label "Treatment with the recombinant interleukin-1 ( IL)-1 ) receptor antagonist anakinra and dexamethasone" .
  
  rdf:SUBJECT-POSITION rdfs:label "74"^^xsd:integer .
  
  rdfs:ABSTRACT-UID ns3:50 "ezgtl5fj" .
  
  rdfs:SENTENCE rdfs:label "Treatment with the recombinant interleukin-1 (IL)-1) receptor antagonist anakinra and dexamethasone resulted in rapid clinical improvement, reduction in serum inflammatory markers and a marked recovery in CMR-based markers of inflammation and contractile dysfunction." .
  
  rdfs:TRIPLE-UID ns2:ezgtl5fj-TRIPLE-ABSTRACT-1 "ezgtl5fj-TRIPLE-ABSTRACT-1" .
  
  <https://uts.nlm.nih.gov/uts/umls/concept/C0229671> rdfs:label "serum" .
  
  <https://uts.nlm.nih.gov/uts/umls/concept/C0245109> rdfs:label "anakinra" .
}

sub:pubInfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
    npx:hasSignature "j8cVcIQ0Qre/l0kFxqoH5z3Xjg1M0TKf/uD7bwC1V/QRGofrvyeghOz4dnj5dECA2Lkx+bH7mnth9aYdYWm1KmZhblhnO9Jd8p46gyTqCjoBn43L2hrgnMXKsWdq0r4Hp2Xj5SgKUN1B8zrjCRj9KmxeQkgzek9P/RBaMONnUVM=";
    npx:hasSignatureTarget this: .
  
  this: prov:generatedAtTime "2021-12-16T20:10:36.592326"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}